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Background 
Methods 
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Subgroup selection criteria 
Inclusion Criteria: Exclusion Criteria: 
 Large vessel occlusion patients 
 Discharged between 1/2014 and 5/2018 
 Age < 18 years 
 Last known well > 24 hours prior to arrival 
 Unknown last known well time 
1,2 3 1,2 3 
Since the dawn of endovascular thrombectomy (EVT), interventionists and stroke clini-
cians have been pushing the boundaries of time (therapeutic window, onset to punc-
ture) and space (lesion location, access to care) to swiftly defuse stroke by extending 
this safe and efficacious treatment to as wide a population as possible. 
With the publication of the 2018 updated acute stroke management guidelines, the 
American Stroke Association recommended extending the therapeutic window of EVT 
for ischemic stroke due to large vessel occlusion (LVO) from 6 hours to 24 hours for se-
lect patients who present with NIHSS ≥ 6.  
The appropriate management of individuals who present with less symptomatic LVO is 
less certain. Anecdotally, many individuals with low presenting NIHSS who are treated 
with EVT do well, while many stroke victims with low initial severity who are medically 
managed may be left with severe stroke-related disability. 
Our objective was to retrospectively analyze stroke patients who presented with LVO 
and low (NIHSS ≤ 5) symptom severity within the Providence system. We were inter-
ested in patient characteristics that increased the likelihood of EVT treatment and 
outcomes of treated vs. untreated patients. Secondary analysis was performed to ex-
plore the role that early clinical deterioration may have played in the decision to treat. 
Retrospective analysis of stroke data from a multi-hospital system. 
Group A Group B Group C 
 
Presenting 
NIHSS ≥ 6 
 
Excluded from 
treatment for 
NIHSS ≤ 5 
  EVT Treated 
Presenting 
NIHSS ≤ 5 
 
Group A vs Group B Group B vs Group C 
 
EVT Treated with NIHSS≤5 
vs patients excluded from 
treatment for “NIHSS≤5” 
EVT Treated with NIHSS≤5 
vs 
EVT Treated with NIHSS≥6 
O
u
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m
es 
• Length of stay 
• Hospital mortality 
• Discharge to Hospice 
• Discharge mRS ≥2 
• Discharge to other than 
home/ARU 
• Symptomatic intracranial 
hemorrhage (sICH) rate 
• Successful reperfusion 
rate 
Treated patients with NIHSS ≤ 5 were 
younger, had higher admit NIHSS, and 
were more likely to be transfers. 
Table 1: 
Patient Characteristics 
Excluded from  
EVT Treatment for 
NIHSS ≤ 5 
EVT Treated with 
NIHSS ≤ 5 
EVT Treated with 
NIHSS ≥ 6 
P-Value P-Value P-Value 
Group A B C A↔B B↔C A↔B↔C 
n 76 65 627 (141) (692) (768) 
Age, mean (SD) 68.96 (14.95) 63.06 (15.98) 70.97 (14.50) 0.025 <0.001 <0.001 
Female, % (n) 48 (36) 48.4 (31) 50.0 (310) 1.000 0.915 0.928 
Hispanic or Latino, % (n) 2.8 (2) 6.5 (4) 8.0 (47) 
0.665 0.489  
White, % (n) 84.5 (60) 82.3 (51) 75.0 (440) 
Admission NIHSS, median [IQR] 2.0 [1.0, 3.0] 3.0 [2.0, 4.0] 18.0 [12.5, 23.0] <0.001 <0.001 0.082 
LKW-to-Door Time, median [IQR] 3.8 [1.3, 7.7] 2.9 [1.0, 5.8] 2.9 [1.0, 5.0] 0.491 0.320 0.491 
EMS Arrival (non-transfer), % (n) 38.2 (29) 42.9 (27) 49.8 (311) 
0.019 0.001 <0.001 Private Car Arrival, % (n) 34.2 (26) 14.3 (9) 3.7 (23) 
Transfer, % (n) 27.6 (21) 42.9 (27) 46.5 (290) 
Onset Rankin % (freq) (n=74) 25.0 (12) 12.5 (3) 24.6 (63) 0.356 0.278  
Comprehensive Stroke Center, % (n) 39.5 (30) 50.8 (33) 41.8 (262) 0.240 0.207 0.329 
Received IV tPA, % (n) 21.1 (16) 23.1 (15) 31.9 (200) 0.932 0.186 0.066 
Atrial fibrillation, % (n) 21.1 (16) 12.3 (8) 24.7 (155) 0.249 0.036 0.070 
Hypertension, % (n) 60.5 (46) 58.5 (38) 70.7 (443) 0.939 0.059 0.036 
Dyslipidemia, % (n) 43.4 (33) 52.3 (34) 46.9 (294) 0.377 0.483 0.569 
Prior Stroke or TIA, % (n) 23.7 (18) 23.1 (15) 23.3 (146) 1.000 1.000 0.996 
Smoker, % (n) 21.1 (16) 18.5 (12) 13.7 (86) 0.863 0.391 0.164 
Table 2. Lesion location for patients presenting with NIHSS ≤ 5  
Internal Carotid 
Artery (ICA) 
Cervical 9.2 (7) 9.2 (6) 
Intracranial 5.3 (4) 0.0 (0) 
Other / UTD 19.7 (15) 3.1 (2) 
Middle Cerebral 
Artery (MCA) 
M1 17.1 (13) 40.0 (26) 
M2 22.4 (17) 33.8 (22) 
M3/M4/Other 7.9 (6) 1.5 (1) 
Vertebral Artery   11.8 (9) 3.1 (2) 
Basilar Artery   5.3 (4) 18.5 (12) 
Other / UTD 23.7 (18) 1.5 (1) 
Statistical analysis: Chi-squared, 
Fisher’s exact, and generalized linear 
and linear multivariable models 
were used to compare outcomes be-
tween groups.  
Subgroup comparison 
Secondary analysis: A paired  
t-test was used to compare  
admission NIHSS and repeat 
NIHSS taken before EVT for 
treated patients who presented 
with NIHSS ≤  5. 
Adjusted statistics: Multivariable 
models (length of stay, in-hospital 
mortality,  discharge mRS ≥ 2,  
discharge to other than home/ARF) 
were adjusted for age, admission 
NIHSS, and last known well (LKWT) to 
door times. 
Figure 1: Outcomes of EVT treated vs excluded patients presenting with NIHSS ≤ 5 
Discharge to other 
than Home/IRF 
 
Discharge mRS ≥ 2 
 
In-Hospital Death  
or Hospice 
There were no significant differences in  
in-hospital mortality or Hospice, discharge 
other than to home or ARF, or discharge 
mRS ≥2.  
 
A significant increase in length of stay was  
observed for EVT-treated patients.  
(Not pictured.) Adjusted percent difference  
(95% CI) = +36.2% (8.1, 64.3); p=0.012. 
Table 3: Outcomes of EVT treated patients presenting with NIHSS ≤ 5 vs NIHSS ≥ 6 
 NIHSS ≤ 5 NIHSS ≥ 6  
Group B C P-Value 
Symptomatic ICH % (n) 3.1 (2) 2.9 (18) 0.711 
Successful reperfusion (TICI ≥ 2b) % (n) 90.3 (56) 85.0 (476) 0.347 
There were no significant 
differences in rate of reper-
fusion or symptomatic ICH 
(sICH) between groups. 
Among the treated patients for 
whom a repeat NIHSS was per-
formed prior to thrombectomy 
(n=37), there was significant early 
clinical deterioration. 
Figure 2: 
Secondary Analysis: Early clinical 
deterioration among LVO patients 
who present with NIHSS ≤ 5 
Treated patients with NIHSS ≤ 5 were 
more likely to have M1 (p < 0.001) or 
basilar artery occlusions (p < 0.001)
and less likely to have vertebral artery 
occlusions (p < 0.001). 
Our analysis of Providence Health System stroke patient data supports the use of 
endovascular thrombectomy to treat ischemic stroke due to large vessel occlusion 
for select patients who present with low symptom severity (NIHSS ≤ 5). 
 
There was no significant difference in the safety (sICH rate) or efficacy (reperfusion 
rate) of EVT treatment for Providence patients presenting with NIHSS ≤ 5 vs those 
presenting with NIHSS ≥ 6. 
 
 
 
Although the length of stay for low NIHSS patients treated with EVT was longer than 
for those who were medically managed, there was no significant difference in compli-
cations or unfavorable outcomes between the two groups.  
 
 
 
Careful patient selection may play an important role in these outcomes—Providence 
interventionists have tended to treat patients who are younger, more symptomatic, 
arrive by transfer, or have M1 MCA or basilar artery lesions. 
 
 
 
Early clinical deterioration was a significant factor among patients for whom a repeat 
NIHSS was recorded prior to EVT treatment.  
Limitations 
This study was a non-randomized, retrospective analysis. As such, we acknowledge the fact 
that our populations are unlikely to have had equivalent baseline characteristics, and have 
been inherently biased by the decision-making of each interventionist. Significant early clinical 
deterioration prior to decision to treat (figure 2) is particularly important reminder of this bias. 
Thus, we recommend the reader interpret with caution any outcome comparisons made here 
between EVT treated and medically managed patients with low presenting NIHSS. 
